Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Total 13F shares
-
64,039,561
-
Share change
-
+2,078,418
-
Total reported value
-
$2,876,045,402
-
Put/Call ratio
-
48%
-
Price per share
-
$44.95
-
Number of holders
-
285
-
Value change
-
+$82,010,320
-
Number of buys
-
147
-
Number of sells
-
135
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2022
As of 31 Dec 2022,
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) was held by
285 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,039,561 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, Champlain Investment Partners, LLC, EMINENCE CAPITAL, LP, BROWN CAPITAL MANAGEMENT LLC, STATE STREET CORP, Bellevue Group AG, and Capital International Investors.
This page lists
286
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.